z-logo
Premium
QuantiFERON‐TB Gold conversion is not uncommon in patients with psoriasis undergoing anti‐tumour necrosis factor‐α therapy
Author(s) -
Megna M.,
Ruggiero A.,
Ferrillo M.,
Fabbrocini G.
Publication year - 2020
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.19310
Subject(s) - medicine , psoriasis , tumor necrosis factor alpha , necrosis , tumor necrosis factor α , dermatology , gastroenterology , surgery
Linked Article: Ya et al. Br J Dermatol 2020; 182 :800–802.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom